Clinical trials
Klinefelter Syndrome trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2018 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Azienda USL Modena | 1 |
| Boston Children's Hospital | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| Hospices Civils de Lyon | 1 |
| Man Clinic for Andrology, Male Infertility and Sexual Dysfunction | 1 |
| Odense University Hospital | 1 |
| RTI International | 1 |
| TC Erciyes University | 1 |
| University of Colorado, Denver | 1 |
| dr. Laura C. G. de Graaff-Herder | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Klinefelter Syndrome | 10 |
| Azoospermia | 2 |
| Turner Syndrome | 2 |
| Addison Disease | 1 |
| Adrenal Hyperplasia, Congenital | 1 |
| Androgen-Insensitivity Syndrome | 1 |
| Angelman Syndrome | 1 |
| Developmental Disabilities | 1 |
| DiGeorge Syndrome | 1 |
| Down Syndrome | 1 |
Trials
Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.